Nicholas Hoffman & Company Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$41.8M |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$40.2M |
| 3 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$20.2M |
| 4 |
Vanguard Mid-Cap ETF
VO
|
+$18.4M |
| 5 |
Vanguard Small-Cap ETF
VB
|
+$6.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Accenture
ACN
|
+$1.04M |
| 2 |
CVS Health
CVS
|
+$650K |
| 3 |
Civista Bancshares
CIVB
|
+$555K |
| 4 |
3M
MMM
|
+$392K |
| 5 |
Unilever
UL
|
+$357K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.84% |
| 2 | Financials | 7.12% |
| 3 | Consumer Staples | 1.93% |
| 4 | Healthcare | 1.77% |
| 5 | Consumer Discretionary | 1.22% |
Similar funds
Nicholas Hoffman & Company's Q2 2024 Portfolio in Review
As of Q2 2024, Nicholas Hoffman & Company held 303 positions worth $2.13B, up 8.2% from $1.97B the previous quarter. Its ten largest holdings account for 74% of the portfolio.
Nicholas Hoffman & Company deployed $135M of net new capital in Q2 2024, opening 12 new positions and adding to 145 existing holdings. Its largest new stake was iShares Russell 1000 Growth ETF: 7,808 shares worth $712K.
By sector, the portfolio is most concentrated in Technology at 7.8% of assets, up from 7.7% a quarter earlier, followed by Financials and Consumer Staples.
On the sell side, the largest reduction was Accenture, an estimated $1.04M trimmed.
- Nicholas Hoffman & Company's largest Q2 2024 buy was iShares Russell 1000 Growth ETF: 7,808 shares worth $712K.
- Nicholas Hoffman & Company added most to Vanguard FTSE Developed Markets ETF in Q2 2024, an estimated $41.8M increase.
- Nicholas Hoffman & Company's biggest Q2 2024 reduction was Accenture, cutting an estimated $1.04M.
- Nicholas Hoffman & Company fully exited CVS Health in Q2 2024, selling an estimated $650K.
- Nicholas Hoffman & Company's ten largest holdings make up 74% of its $2.13B portfolio in Q2 2024.
- Nicholas Hoffman & Company opened 12 new positions and closed 18 in Q2 2024.
- Nicholas Hoffman & Company's portfolio value rose 8.2% quarter-over-quarter to $2.13B.
Based on Nicholas Hoffman & Company's 13F filing for Q2 2024, filed 2 Aug 2024.